Exact Mass: 442.1812036
Exact Mass Matches: 442.1812036
Found 210 metabolites which its exact mass value is equals to given mass value 442.1812036
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Lusitanicoside
Isolated from cherries (Prunus lusitanica). Lusitanicoside is found in sweet marjoram and fruits. Lusitanicoside is found in fruits. Lusitanicoside is isolated from cherries (Prunus lusitanica).
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
C16H31N2O10P (442.17162360000003)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is an acylcarnitine. More specifically, it is an 3-[(2R)-2-hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
Tyrosyl-glycyl-glycyl-phenylalanyl
Hydrocortisone phosphate
(7,8-Dihydro-5-((E)-((a-(3-pyridyl)benzylidene)aminooxy)ethyl)-1-naphthyloxy)acetic acid
C27H26N2O4 (442.18924760000004)
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-4,14-dihydroxy-3-methoxy-19-methyl-, (21.alpha.,22.alpha.)-
15-O-??-D-Glucopyranosyl-11??,13-dihydrourospermal A
(1S,3R,5S,6S,8S,9S,10R,13R)-1-acetoxy-3-bromo-6-hydroxy-8,13-epoxylabd-14-ene
C22H35BrO4 (442.17185700000005)
(8Z)-decaene-4,6-diyn-1-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside
beta-D-glucopyranosyl phaseate|[1R-[1alpha,5alpha,8S*(2Z,4E)]]-1-O-[5-(8-hydroxy-1,5-dimethyl-3-oxo-6-oxabicyclo[3.2.1]oct-8-yl)-3-methyl-2,4-pentadienoyl]-beta-D-glucopyranose
3beta,4alpha-dihydroxy-4-beta-(chloromethyl)-8alpha-(4-hydroxymethacrylate)-11beta,13-dihydro-13-isopropyl-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14)-en-6,12-olide|Diain
2R,3R-13-hydroxypterosin L 3-O-beta-D-glucopyranoside
3,4,17-trihydroxy-6,7-didehydro-aspidofractinine-1,3-dicarboxylic acid dimethyl ester|ent-(2S)-3alpha,4xi,17-Trihydroxy-6,7-didehydro-aspidofractinin-1,3beta-dicarbonsaeure-dimethylester|ent-(2S)-3alpha,4xi,17-trihydroxy-6,7-didehydro-aspidofractinine-1,3beta-dicarboxylic acid dimethyl ester|Kopsaporin
Lincomycin hydrochloride
C18H35ClN2O6S (442.19042400000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
C21H30O10_(2E,4E)-5-{6-[(beta-D-Glucopyranosyloxy)methyl]-1-hydroxy-2,6-dimethyl-4-oxo-2-cyclohexen-1-yl}-3-methyl-2,4-pentadienoic acid
C21H30O10_4-Allylphenyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
Ala Asp His Thr
Ala Asp Thr His
Ala Glu His Ser
Ala Glu Ser His
Ala His Asp Thr
Ala His Glu Ser
Ala His Ser Glu
Ala His Thr Asp
Ala Ser Glu His
Ala Ser His Glu
Ala Thr Asp His
Ala Thr His Asp
Asp Ala His Thr
Asp Ala Thr His
Asp His Ala Thr
Asp His Thr Ala
Asp Thr Ala His
Asp Thr His Ala
Glu Ala His Ser
Glu Ala Ser His
Glu Gly His Thr
Glu Gly Thr His
Glu His Ala Ser
Glu His Gly Thr
Glu His Ser Ala
Glu His Thr Gly
Glu Ser Ala His
Glu Ser His Ala
Glu Thr Gly His
Glu Thr His Gly
Phe Gly Gly Tyr
Phe Gly Tyr Gly
Phe Tyr Gly Gly
Gly Glu His Thr
Gly Glu Thr His
Gly Phe Gly Tyr
Gly Phe Tyr Gly
Gly Gly Phe Tyr
Gly Gly Tyr Phe
Gly His Glu Thr
Gly His Thr Glu
Gly Thr Glu His
Gly Thr His Glu
Gly Tyr Phe Gly
Gly Tyr Gly Phe
His Ala Asp Thr
His Ala Glu Ser
His Ala Ser Glu
His Ala Thr Asp
His Asp Ala Thr
His Asp Thr Ala
His Glu Ala Ser
His Glu Gly Thr
His Glu Ser Ala
His Glu Thr Gly
His Gly Glu Thr
His Gly Thr Glu
His Ser Ala Glu
His Ser Glu Ala
His Thr Ala Asp
His Thr Asp Ala
His Thr Glu Gly
His Thr Gly Glu
Ser Ala Glu His
Ser Ala His Glu
Ser Glu Ala His
Ser Glu His Ala
Ser His Ala Glu
Ser His Glu Ala
Thr Ala Asp His
Thr Ala His Asp
Thr Asp Ala His
Thr Asp His Ala
Thr Glu Gly His
Thr Glu His Gly
Thr Gly Glu His
Thr Gly His Glu
Thr His Ala Asp
Thr His Asp Ala
Thr His Glu Gly
Thr His Gly Glu
Tyr Phe Gly Gly
Tyr Gly Phe Gly
Tyr Gly Gly Phe
Hydrocortisone phosphate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
1-Boc-4-[4-(3,4-dichlorophenoxy)piperidin-1-ylmethyl]piperidine
C22H32Cl2N2O3 (442.17898619999994)
Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane
C27H26N2O4 (442.18924760000004)
2-[4-[(4-ethoxyphenyl)methylamino]phenyl]-1-ethylbenz[cd]indolium chloride
C28H27ClN2O (442.18118020000003)
2-amino-5-[phenylmethoxycarbonyl-[(E)-N-phenylmethoxycarbonylcarbamimidoyl]amino]pentanoic acid
AZD9496
C25H25F3N2O2 (442.18680259999996)
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2116 - Selective Estrogen Receptor Down Regulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist
Benzene, 1,1-(1,2-diphenyl-1,2-ethenediyl)bis[4-(azidoMethyl)-
(2E,4E)-5-[1-hydroxy-2,6-dimethyl-4-oxo-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]cyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid
Tyrosyl-glycyl-glycyl-phenylalanyl
(7,8-Dihydro-5-((E)-((a-(3-pyridyl)benzylidene)aminooxy)ethyl)-1-naphthyloxy)acetic acid
C27H26N2O4 (442.18924760000004)
3-[(2R)-2-Hydroxy-3-methyl-3-[(phosphonooxy)methyl]butanamido]propanoylcarnitine
C16H31N2O10P (442.17162360000003)
5-tert-butyl-N-[[3-[(2,4-difluorophenoxy)methyl]-4-methoxyphenyl]methylideneamino]-1H-pyrazole-3-carboxamide
8-[(1-tert-butyl-5-tetrazolyl)-thiomorpholin-4-ylmethyl]-3,6-dihydro-2H-[1,4]dioxino[2,3-g]quinolin-7-one
C21H26N6O3S (442.17870060000007)
[2-[(11S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] dihydrogen phosphate
(2E)-3-phenyl-2-propen-1-yl-6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
[(3aS,4S,9bR)-8-[2-(2-fluorophenyl)ethynyl]-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-(2-pyrazinyl)methanone
C26H23FN4O2 (442.18049499999995)
1-[(2R,3S)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
1-[(2S,3S)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2,2,2-trifluoroethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
(1S)-N-(2,4-difluorophenyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
1-[(2S,3R)-3-[4-(3-fluorophenyl)phenyl]-2-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-1,6-diazaspiro[3.3]heptan-6-yl]-2-methoxyethanone
(2S)-3-Methyl-2-((2R,3S)-3-[(methylsulfonyl)amino]-1-{[2-(pyrrolidin-1-ylmethyl)-1,3-oxazol-4-YL]carbonyl}pyrrolidin-2-YL)butanoic acid
Lincocin
C18H35ClN2O6S (442.19042400000006)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
methyl (1R,9S,10R,11R,17S)-14-ethenyl-13-(2-hydroxyacetyl)oxy-12,21-dioxa-8,18-diazahexacyclo[9.9.1.01,9.02,7.09,17.010,15]henicosa-2,4,6-triene-10-carboxylate
4,6-dihydroxy-6-methyl-3,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
23-hydroxy-17,18-dimethoxy-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15(20),16,18-triene-21,24-dione
2-[2-(4-{2-hydroxy-5-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,4-diol
(3s,3ar,4s,11ar)-4-hydroxy-3-methyl-2-oxo-10-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
(1s,4as,7as)-4-({[(2r,3s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-oxooxan-2-yl]oxy}methyl)-7-(hydroxymethyl)-1h,4ah,5h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate
3-{3-[3-(3-hydroxy-5-methylphenoxy)-5-methylphenoxy]-5-methylphenoxy}-5-methylphenol
5-[2-(3-hydroxyphenyl)ethyl]-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}benzene-1,2-diol
3-hydroxy-11-isopropyl-6-methyl-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-9-oxatricyclo[6.2.1.0²,⁶]undec-4-ene-7,10-dione
15-o-β-d-glucopyranosyl-11β,13-dihydro-urospermal a
{"Ingredient_id": "HBIN001706","Ingredient_name": "15-o-\u03b2-d-glucopyranosyl-11\u03b2,13-dihydro-urospermal a","Alias": "NA","Ingredient_formula": "C21H30O10","Ingredient_Smile": "CC1C2C(CC(=CCCC(=CC2OC1=O)COC3C(C(C(C(O3)CO)O)O)O)C=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "8614","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(1's,6'r)-8'-hydroxyabscisicacid β-d-glucoside
{"Ingredient_id": "HBIN003319","Ingredient_name": "(1's,6'r)-8'-hydroxyabscisicacid \u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O10","Ingredient_Smile": "CC1=CC(=O)CC(C1(C=CC(=CC(=O)O)C)O)(C)COC2C(C(C(C(O2)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9747","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2r,3r,4s,5s,6r)-2-[(8z)-dec-8-en-4,6-diyn-1-yloxy]-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)oxane-3,4,5-triol
16,23-dihydroxy-17-methoxy-4-methyl-7,10-dioxa-4,14-diazaheptacyclo[10.8.3.2¹¹,¹⁴.0¹,¹³.0⁶,⁸.0⁶,²³.0¹⁵,²⁰]pentacosa-15,17,19-triene-21,24-dione
13,15-dimethyl (1s,2r,6r,14s,15r,16r,18s,20s)-15,20-dihydroxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
2-[4-(prop-2-en-1-yl)phenoxy]-6-{[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]methyl}oxane-3,4,5-triol
3-[2-(4-hydroxy-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,2-diol
13,15-dimethyl 15,20-dihydroxy-17-oxa-3,13-diazaheptacyclo[12.6.2.0¹,¹⁶.0²,⁶.0³,¹⁸.0⁶,¹⁴.0⁷,¹²]docosa-7,9,11-triene-13,15-dicarboxylate
(1s,2s,3r,6r,8r,11s)-3-hydroxy-11-isopropyl-6-methyl-5-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-9-oxatricyclo[6.2.1.0²,⁶]undec-4-ene-7,10-dione
5-[2-(4-hydroxyphenyl)ethyl]-4,6-bis[(4-hydroxyphenyl)methyl]benzene-1,3-diol
2-[2-(4-hydroxy-3-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenyl)ethyl]benzene-1,4-diol
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (2z,4e)-5-[(1r,5r,8s)-8-hydroxy-1,5-dimethyl-3-oxo-6-oxabicyclo[3.2.1]octan-8-yl]-3-methylpenta-2,4-dienoate
(2s,3r,4s,5s,6r)-2-[4-(prop-1-en-1-yl)phenoxy]-6-({[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(2s,3r,4r,5r,6r)-2-methyl-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e)-3-phenylprop-2-en-1-yl]oxy}oxan-2-yl]methoxy}oxane-3,4,5-triol
5-[1-hydroxy-2,6-dimethyl-4-oxo-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)cyclohex-2-en-1-yl]-3-methylpenta-2,4-dienoic acid
(3r,4as,6s,6as,8r,10s,10ar,10bs)-8-bromo-3-ethenyl-6-hydroxy-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-10-yl acetate
C22H35BrO4 (442.17185700000005)